COMMUNIQUÉS West-GlobeNewswire

INSYS Therapeutics to Present at J.P. Morgan Healthcare Conference
03/01/2018
PHOENIX, Jan. 03, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), announced today that Saeed Motahari, president and chief executive officer, and Andrew Long, chief financial officer, will present at [...]
OrthoPediatrics Corp. Expands PediPlates® Franchise with Titanium System
03/01/2018
WARSAW, Ind., Jan. 03, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS ), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce the launch of Titanium [...]
Editas Medicine to Present at the 36th Annual J.P. Morgan Healthcare Conference
03/01/2018
CAMBRIDGE, Mass., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT ), a leading genome editing company, today announced that it will present a company overview followed by a question and answer [...]
CV Sciences, Inc. to Present at the Biotech Showcase™ 2018
03/01/2018
LAS VEGAS, Jan. 03, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. , (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), preeminent supplier and manufacturer of hemp-derived phytocannabinoids, including CBD oil and [...]
Spark Therapeutics Announces First-of-their-kind Programs to Improve Patient Access to LUXTURNA™ (voretigene neparvovec-rzyl), a One-time Gene Therapy Treatment
03/01/2018
Company offers outcomes-based rebates and an innovative contracting model that support patient access in the U.S. while aiming to reduce risk and financial burden for payers and treatment centers Harvard Pilgrim and [...]
Bellerophon Announces First Patient Enrolled in Phase 2b Study Evaluating INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
03/01/2018
WARREN, N.J., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH ), a clinical-stage biotherapeutics company, today announced that the first patient has been randomized into a Phase 2b study [...]
Agritek Holdings, Inc. Announces Availability Of New Microdose Strips Oral Tabs For New California Recreational And Medical Cannabis Markets For 2018
03/01/2018
LOS ANGELES, CA, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector and consultant for multiple [...]
ChemoCentryx to Present at the 36th Annual J.P. Morgan Healthcare Conference
03/01/2018
MOUNTAIN VIEW, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI ), a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer, today [...]
Acer Therapeutics to Present at the Biotech Showcase™ 2018 Conference
03/01/2018
NEWTON, Mass., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER ), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra- [...]
Anthera Pharmaceuticals Announces Appointment of Patrick Murphy as Senior Vice President, Manufacturing
03/01/2018
HAYWARD, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ) today announced the appointment of Patrick Murphy as Senior Vice President, Manufacturing. Patrick brings over 35 years of [...]
Zosano Pharma Announces Notice of Allowance for a U.S. Patent Application Covering M207 as an Acute Treatment for Migraine
03/01/2018
FREMONT, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corp. (NASDAQ: ZSAN ) (“Zosano” or the “Company”) a clinical stage biopharmaceutical company focused on providing rapid systemic administration of [...]
Avinger Announces Treatment of First Patients Globally With Next Generation Pantheris
03/01/2018
REDWOOD CITY, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), announced that Arne Schwindt, M.D., a vascular [...]
Orion Corporation: Managers' transactions - Ylppö Jukka
03/01/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 03 JANUARY 2018 at 15.10 EET Orion Corporation: Managers' transactions - Ylppö Jukka Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]
Altimmune Elects Mitchel Sayare, Ph.D. as Chairman of its Board of Directors
03/01/2018
Current Chairman, David Drutz, M.D., remains Chairman of Compensation Committee and Member of the Board GAITHERSBURG, Md., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage [...]
Diffusion Pharmaceuticals to Present at the 10th Annual Biotech Showcase™ Conference
03/01/2018
CHARLOTTESVILLE, Va., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN ) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on extending the life expectancy of [...]
Jounce Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference
03/01/2018
CAMBRIDGE, Mass., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE ), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers [...]
BioSig Technologies Appoints New Chief Financial Officer to Facilitate Growth Trajectory
03/01/2018
Santa Monica, CA, Jan. 03, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
ClearCorrect’s Flex and Unlimited pricing now available in Canada
03/01/2018
ROUND ROCK, Texas, Jan. 03, 2018 (GLOBE NEWSWIRE) -- ClearCorrect, LLC, a leading manufacturer of clear aligners, released their Flex ™ and Unlimited ™ pricing options to dentists and orthodontists in Canada on January [...]
Foamix Names Mr. David Domzalski as a Member of the Board of Foamix Pharmaceuticals
03/01/2018
REHOVOT, Israel and BRIDGEWATER, N.J., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX ) (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and [...]

Pages